Glycosyl-phosphatidyl-inositol-defective granulocytes from paroxysmal nocturnal haemoglobinuria patients show increased bacterial ingestion but reduced respiratory burst induction

American Journal of Hematology

Volumn 82, Issue 2, 2007, Pages 98-107

  Cacciapuoti, Carmela ^a   Terrazano, Giuseppe ^a   Barone, Lucia ^a   Sica, Michela ^a   Becchimanzi, Cristina ^a   Rotoli, Bruno ^a   Ruggiero, Giuseppina ^a   Alfinito, Fiorella ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Granulocytes; Oxidative burst; Paroxysmal nocturnal haemoglobinuria; Phagocytosis

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; GLYCOSYLPHOSPHATIDYLINOSITOL; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ESCHERICHIA COLI; FEMALE; GRANULOCYTE; GRANULOCYTE FUNCTION; HUMAN; HUMAN CELL; MALE; NEUTROPENIA; OPSONIZATION; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATHOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST;

ADULT; ANIMALS; CARCINOGENS; CELLS, CULTURED; ENZYME ACTIVATION; ESCHERICHIA COLI; GLYCOSYLPHOSPHATIDYLINOSITOLS; GRANULOCYTES; GRANULOMATOUS DISEASE, CHRONIC; HEMATOPOIESIS; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; MALE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPENIA; PHAGOCYTOSIS; PROTEIN KINASE C; RESPIRATORY BURST; TETRADECANOYLPHORBOL ACETATE;

EID: 33846554212     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20779     Document Type: Article

References (58)

1. Takeda J, Miyata T, Kawagoe K, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 1993;73:703-711.
2. Bessler M, Mason PJ, Hillmen P, et al. Paroxysmal nocturnal hemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J 1994;13:110-117.
3. Rotoli B, Luzzatto L. Paroxysmal nocturnal hemoglobinuria. Baillieres Clin Haematol 1989;2:113-138.
4. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinuria. New Engl J Med 1995;333:1253-1258.
5. Wilcox LA, Ezzell JL, Bernshaw NJ, Parker CJ. Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum. Blood 1991;78:820-829.
6. Gralnick H, Vail M, McKeon LP, et al. Activated platelet in paroxysmal nocturnal hemoglobinuria. Br J Haematol 1995;91:697-702.
7. Luzzatto L, Bessler M, Rotoli B. Somatic mutations in paroxysmal nocturnal hemoglobinuria: A blessing in disguise? Cell 1997; 88:1-4.
8. Karadimitris A, Manavalan JS, Thaler HT, et al. Abnormal T cell repertoire is consistent with immune process underlying the
9. pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood 2000;96:2613-2620.
10. Terrazzano G, Sica M, Becchimanzi C, et al. T cells from paroxysmal nocturnal haemoglobinuria (PNH) patients show an altered CD40-dependent pathway. J Leukoc Biol 2005;8:26-36.
11. Alfinito F, Del Vecchio L, Rocco S, Musto P, Rotoli B. Blood cell flow cytometry in paroxysmal nocturnal hemoglobinuria: A tool for measuring the extent of PNH clone. Leukemia 1996;10:1326-1330.
12. Richards SJ, Rawstron AC, Hillmen P. Application of cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry 2000;42:223-233.
13. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996;272:50-53.
14. Pedersen TL, Yong K, Pedersen JO, Hauren NE, Dano K, Plesner T. Impaired migration in vitro of neutrophils with PNH. Br J Haematol 1995;94:45-51.
15. Hundt M, Schubert J, de Haas M, Zielinska-Skowronek M, Schmidt E. The loss of FcgRIIIb in paroxysmal nocturnal hemoglobinuria is functionally replaced by FcgRII. Blood 1994;83: 3574-3580.
16. Yamamoto T. Granulocytes from patients with paroxysmal nocturnal hemoglobinuria and normal individuals have the same sensitivity to spontaneous apoptosis. Exp Hematol 2002;30:187-194.
17. Funaro A, Ortolan E, Feranti B, et al. CD157 is an important mediator of neutrophil adhesion and migration. Blood 2004;104: 4269-4278.
18. Suzuki K, Watanabe T, Sakurai S-I, et al. A novel glycosylphospatidyl inositol-anchored protein on human leukocytes: A possible role for regulation of neutrophil adherence and migration. J Immunol 1999;162:4277-4284.
19. Schutt C, Schilling T, Grunwald U, et al. Human monocytes lacking the membrane-bound form of the bacterial lipopolysaccharide (LPS) receptor CD14 can mount on LPS-induced oxidative burst response mediated by a soluble form of CD14. Res Immunol 1995;146:339-350.
20. Underhill DM, Ozinsky A. Phagocytosis of microbes: Complexity in action. Annu Rev Immunol 2002;20:825-852.
21. Henneke P, Golenbock DT. Phagocytosis, innate immunity and host-pathogen specificity. J Exp Med 2004;199:1-4.
22. Stuart LM, Ezekowitz P. Phagocytosis: Elegant complexity. Immunity 2005;22:539-550.
23. Greenberg S, Grinstein S. Phagocytosis and innate immunity. Curr Opin Immunol 2002;14:136-145.
24. Massol P, Montcourrier P, Guillemot JC, Chavrier P. Fc receptor-mediated phagocytosis requires CDC42 and Rac1. EMBO J 1998;17:6219-6229.
25. Caron E, Hall A. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 1998; 11:1717-1721.
26. Lorenzi R, Brickell PM, Katz DR, Kinnon C, Thrasher AJ. Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis. Blood 2000;95:2943-2946.
27. Zhang Q. Calafat J, Janssen H, Greenberg S. ARF6 is required for growth factor- and Rac-mediated membrane ruffling in macrophages at a stage distal to Rac membrane targeting. Mol Cell Biol 1999;19:8158-8168.
28. Fitzer-Attas CJ, Lowry M, Crowley MT, et al. Fcg receptor-mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr and Lyn. J Exp Med 2000;191:669-682.
29. Crowley MT, Costello PS, Fitzer-Attas CJ, et al. A critical role for Syk in signal transduction and phagocytosis mediated by Fcg receptor on macrophages. J Exp Med 1997;186:1027-1039.
30. Marshall IJ, Booth JW, Stambolic V, Mak T, Balla T, Schreiber AD. Restricted accumulation of phosphatidyl-inositol 3-kinase products in a plasmalemmal subdomain during Fcg receptor-mediated phagocytosis. J Cell Biol 2001;153:1369-1380.
31. Botelho RJ, Teruel M, Dierckaman R, et al. Localised biphasic changes in phosphatidylinositol-4,5-biphosphate at sites of phagocytosis. J Cell Biol 2000;151:1353-1368.
32. Melendez AJ, Hamett MM, Allen JM. FcgR1 activation of phospholipase Cg1 and protein kinase C in dibutyryl cAMP-diferentiated U937 cells is dependent solely on the tyrosine-kinase activated form of phosphatidyl-inositol-3-kinase. Immunology 1999;98:1-8.
33. Ydrenius L, Majeed M, Rasmusson BJ, Stendahl O, Sarndahl E. Activation of cAMP-dependent protein kinase is necessary for actin rearrangements in human neutrophils during phagocytosis. J Leukoc Biol 2000;67:520-528.
34. Lennartz MR, Yuen AFC, Masi SM, Russel DG, Buttle FK, Smith JJ. Phospholipase A2 inhibition results in sequestration of plasma membrane into electron-lucent vesicles during IgG-mediated phagocytosis. J Cell Sci 1999;110:2041-2052.
35. Kusner DJ, Hall CF, Jackson S. Fcg receptor-mediated activation of phospholipase D regulates macrophage phagocytosis of IgG-opsonised particles. J Immunol 1999;162:2266-2274.
36. Buyon JP, Slade SJ, Reibman J, Abramson SB, Philips MR, Weissmann G. Constitutive and induced phosphorilaton of the α and β chains of the CD11/CD18 integrin family. Relationship to adhesion-dependent functions. J Immunol 1990;144: 191-197.
37. Allen L-A, Aderen A. Molecular definition of distinct cytoskeletal structures involved in complement- and Fc receptor-mediated phagocytosis in macrophages. J Exp Med 1996;184:627-637.
38. DeLeo FR, Allen LA, Apicella M, Nauseef WN. NADPH oxidase activation and assembly during phagocytosis. J Immunol 1999; 163:6732-6740.
39. Gresham HD, McGarr JA, Shackelford PG, Brown EJ. Studies on the molecular mechanism of human Fc receptor-mediated phagocytosis. Amplification of ingestion is dependent on the generation of reactive oxygen metabolites and is deficient in polymorphonuclear leukocytes from patients with chronic granulomatous disease. J Clin Invest 1988;82:1192-1201.
40. Serrander L, Larsson J, Lundqvist H, Lindmark M, Fallman M. Dahlgren C, et al. Particles binding β(2)-integrins mediate intracellular production of oxidative metabolites in human neutrophils independently of phagocytosis. Biochim Biophys Acta 1999;1452: 133-144.
41. phox and on NADPH oxidase activation. Biochemistry 2002;41:7743-7749.
42. von Knethen A, Tautenhahn A, Link H, Lindemann D, Brune B. Activation-induced depletion of protein kinase Ca provokes desentization of monocytes/macrocrophages in sepsis. J Immunol 2005;174:4960-4965.
43. Goldblatt D, Thrasher AJ. Chronic granulomatous disease. Clin Exp Immunol 2000;122:1-9.
44. Vowells SJ, Sekhsaria S, Malech HL, Shalit M, Fleisher TA. Flow cytometric analysis of the granulocyte respiratory burst: A comparison study of fluorescent probes. J Immunol Methods 1995;178:89-97.
45. Miele C, Riboulet A, Maitani MA, et al. Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling trough a Protein Kinaùse C-mediarted mechanism. J Biol Chem 2003;278:47376-47387.
46. Snhnitzler N, Haase G, Podblielski A, Lutticken R, Schweizer KG. A costimulatory signal through ICAM-b2 integrin-binding potentiates neutrophil phagocytosis. Nat Med 1999;5:231-235.
47. Braun DC, Cao Y, Wang S, Garfield SH, Min Hur G, Blumberg PM. Role of phorbol ester localization in determining protein kinase C or Ras GRP3 translocation: Real-time analysis using fluorescent ligands and proteins. Mol Cancer Ther 2005; 4:141-150.
48. Martins PS, Kallas EG, Neto MC, Dalboni MA, Blecher S, Salomao R. Upregulation of reactive oxygen species generation and phagocytosis and increased apoptosis in human neutrophils during severe sepsis and septic shock. Shock 2003;20:208-211.
49. Tan SL, Parker PJ. Emerging and diverse roles of protein kinase C in immune cell signalling. Biochem J 2003;376:545-552.
50. Barandier C, Ming XF, Rusconi S, Yang Z. PKC is required for activation of ROCK by RhoA in human endothelial cells. Biochem Biophys Res Commun 2003;304:714-719.
51. Sehgal G, Zang K, Todd RF, Boxer LA, Petty HR. Lectin-like inhibition of immune complex receptor-mediated stimulation of neutrophils. Effects on cytosolic calcium release and super-oxide production. J Immunol 1993;150:4571-4580.
52. Berger M, O'Shea J, Cross AS, et al. Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. J Clin Invest 1984;74:1566-1571.
53. Stern M, Rosse WF. Two populations of granulocytes in paroxysmal nocturnal hemoglobinuria. Blood 1979;53:928-934.
54. Tauber AI, Borregaard N, Simons E, Wright J. Chronic granulomatous disease: A syndrome of phagocyte oxidase deficiency. Medicine 1983;62:286-302.
55. Lehmann AK, Sornes S, Halstensen A. Phagocytosis: Measurement by flow cytometry. J Immunol Methods 2000;243:229-242.
56. Iles KE, Forman HJ. Macrophage signalling and respiratory burst. Immunol Res 2002;26:95-99.
57. BoKoch GM, Diebold BA. Current molecular models for NADPH oxidase regulation by Rac GTPase. Blood 2002;100:2692-2698.
58. Socié G, Mary JY, de Gramont A, et al. Paroxysmal nocturnal haemoglobinuria: Long-term follow-up and prognostic factors. Lancet 1996;348:573-577.